Development Level

Tbio 29 | 11,445
Tchem 15 | 1,598
Tclin 2 | 613
Tdark 2 | 6,588

IMPC Phenotype

preweaning lethality, complete... 5 | 979
decreased circulating glucose ... 3 | 126
embryonic lethality prior to o... 3 | 239
embryonic lethality prior to t... 3 | 278
decreased circulating creatini... 2 | 39
decreased mean corpuscular vol... 2 | 79
improved glucose tolerance 2 | 79
increased grip strength 2 | 41
increased mean corpuscular hem... 2 | 96
preweaning lethality, incomple... 2 | 499
abnormal embryo size 1 | 220
abnormal eye morphology 1 | 68
abnormal motor learning 1 | 3
abnormal sleep behavior 1 | 70
abnormal snout morphology 1 | 23
decreased bone mineral content 1 | 151
decreased circulating alkaline... 1 | 46
decreased circulating amylase ... 1 | 28
decreased circulating free fat... 1 | 31
decreased circulating triglyce... 1 | 79
decreased coping response 1 | 8
decreased erythrocyte cell num... 1 | 62
decreased granulocyte number 1 | 6
decreased hematocrit 1 | 46
decreased hemoglobin content 1 | 68
decreased lean body mass 1 | 135
decreased mean corpuscular hem... 1 | 50
decreased mean corpuscular hem... 1 | 31
decreased mean platelet volume 1 | 25
enlarged heart 1 | 210
enlarged uterus 1 | 11
hydrometra 1 | 53
increased circulating alkaline... 1 | 122
increased circulating bilirubi... 1 | 16
increased circulating choleste... 1 | 66
increased circulating glycerol... 1 | 9
increased circulating iron lev... 1 | 30
increased circulating serum al... 1 | 22
increased circulating total pr... 1 | 28
increased kidney weight 1 | 6
increased mean corpuscular vol... 1 | 92
increased total body fat amoun... 1 | 134
male infertility 1 | 123
short tibia 1 | 97
small superior vagus ganglion 1 | 74
thrombocytopenia 1 | 56

Disease

ovarian cancer 31 | 8,520
Carcinoma 26 | 11,493
psoriasis 26 | 6,694
Cancer 24 | 2,499
glioblastoma 22 | 5,792
lung cancer 21 | 4,740
osteosarcoma 20 | 7,950
medulloblastoma, large-cell 17 | 6,241
diabetes mellitus 16 | 1,728
atypical teratoid / rhabdoid tumor 13 | 5,112
interstitial cystitis 13 | 2,312
lung carcinoma 13 | 2,843
malignant mesothelioma 13 | 3,232
Autosomal recessive predisposition 12 | 1,442
Schizophrenia 12 | 1,160
adult high grade glioma 12 | 3,801
ependymoma 12 | 4,679
intraductal papillary-mucinous carcinoma (IPMC) 12 | 2,989
invasive ductal carcinoma 12 | 2,951
lung adenocarcinoma 12 | 2,716
Breast cancer 11 | 3,578
Hypertension 11 | 396
Obesity 11 | 678
Hypertensive disease 10 | 292
Seizures 10 | 596
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,291
juvenile dermatomyositis 10 | 1,187
oligodendroglioma 10 | 2,850
pancreatic ductal adenocarcinoma liver metastasis 10 | 1,962
tuberculosis 10 | 2,010
Bipolar Disorder 9 | 666
Kidney disease 9 | 430
cystic fibrosis 9 | 1,696
non-small cell lung cancer 9 | 2,890
Alzheimer's disease 8 | 658
Astrocytoma, Pilocytic 8 | 3,081
Breast Neoplasms 8 | 445
Epilepsy 8 | 792
Liver Cirrhosis, Experimental 8 | 769
Mammary Neoplasms 8 | 425
group 3 medulloblastoma 8 | 4,104
group 4 medulloblastoma 8 | 1,855
Arthritis 7 | 290
Cerebrovascular disease 7 | 238
Depressive disorder 7 | 409
Down syndrome 7 | 499
Hyperalgesia 7 | 83
Myopathy 7 | 185
Prostatic Neoplasms 7 | 495
Vascular disease 7 | 319
astrocytic glioma 7 | 2,597
pancreatic cancer 7 | 2,398
Asthma 6 | 385
Atherosclerosis 6 | 291
Big calvaria 6 | 147
Chemical and Drug Induced Liver Injury 6 | 195
Coronary artery disease 6 | 268
Diabetic retinopathy 6 | 56
Diarrhea 6 | 253
Duchenne muscular dystrophy 6 | 601
Heart failure 6 | 162
Hyperglycemia 6 | 137
Increased head circumference 6 | 147
Increased size of cranium 6 | 147
Increased size of skull 6 | 147
Inflammation 6 | 120
Mental Depression 6 | 333
Mood swings 6 | 77
Multiple myeloma 6 | 1,332
Muscle Spasticity 6 | 195
Myocardial Ischemia 6 | 169
Neurodegenerative disease 6 | 414
Optic Atrophy 6 | 242
Pulmonary Fibrosis 6 | 106
Toxic encephalopathy 6 | 141
Waldenstrons macroglobulinemia 6 | 765
acute quadriplegic myopathy 6 | 1,158
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 510
breast carcinoma 6 | 1,638
primitive neuroectodermal tumor 6 | 3,035
subependymal giant cell astrocytoma 6 | 2,287
ulcerative colitis 6 | 1,819
Anemia 5 | 365
Brain Ischemia 5 | 110
Dementia 5 | 175
Heart disease 5 | 306
Hypersensitivity reaction type II disease 5 | 253
Inflammatory bowel disease 5 | 151
Lipid metabolism disorder 5 | 114
Malaria 5 | 160
Personality change 5 | 23
Pick disease 5 | 1,894
Secondary physiologic amenorrhea 5 | 32
adrenocortical carcinoma 5 | 1,428
colon cancer 5 | 1,478
dermatomyositis 5 | 966
esophageal adenocarcinoma 5 | 737
pediatric high grade glioma 5 | 1,064
pituitary cancer 5 | 1,972

Tissue

Digestive Tract 46 | 17,369
Endocrine System 46 | 18,159
Liver and Pancreas 46 | 16,750
Female tissues 45 | 17,400
Skin and soft tissues 45 | 17,230
Blood and immune system 44 | 16,909
Male tissues 44 | 17,142
Nervous System 44 | 16,725
Urinary Tract 44 | 16,678
Respiratory system 42 | 16,393
Cardiovascular System 39 | 15,192

Target Family

Non-IDG 32 | 12,091
Enzyme 5 | 4,145
Ion Channel 4 | 344
Kinase 4 | 634
Epigenetic 1 | 242
GPCR 1 | 408
Transporter 1 | 473

GO Process

response to heat 48 | 48
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transient receptor potential cation channel subfamily V member 2 TRPV2 Tchem Ion Channel -2.28525 197.9 203
DnaJ homolog subfamily A member 4 DNAJA4 Tbio Non-IDG -0.52235 2.67 120
Heat shock-related 70 kDa protein 2 HSPA2 Tbio Non-IDG -1.98655 104.3 162
Acid-sensing ion channel 3 ASIC3 Tchem Ion Channel -2.28745 195.8 130
Translation initiation factor eIF-2B subunit delta EIF2B4 Tbio Non-IDG -1.06082 11.3 145
Somatostatin SST Tbio Non-IDG -4.14886 13572.0 397
Cytochrome b MT-CYB Tbio Non-IDG -3.77047 5856.5 134
Low-density lipoprotein receptor-related protein 11 LRP11 Tdark Non-IDG -0.62553 4.15 56
Pyruvate kinase PKLR PKLR Tbio Kinase -2.37549 231.1 391
C-C motif chemokine 2 CCL2 Tchem Non-IDG -3.84820 7088.3 1260